Prophylactic Treatment for UTIs in Patients with Bacterial Vaginosis

Treatment of Underlying Bacterial Vaginosis

The Centers for Disease Control and Prevention recommends metronidazole 500 mg orally twice a day for 7 days as a treatment regimen for bacterial vaginosis 2, 3
The Centers for Disease Control and Prevention recommends metronidazole gel 0.75%, one full applicator (5 g) intravaginally, once a day for 5 days as an alternative treatment regimen for bacterial vaginosis 2
The Centers for Disease Control and Prevention recommends clindamycin cream 2%, one full applicator (5 g) intravaginally at bedtime for 7 days as an alternative treatment regimen for bacterial vaginosis 2, 3

The American Urological Association recommends daily antibiotic prophylaxis for 6-12 months to prevent recurrent UTIs 1
The American Urological Association recommends common prophylactic antibiotics, including TMP, TMP-SMX, nitrofurantoin, and cephalexin, for preventing recurrent UTIs 1
The American Urological Association recommends post-coital antibiotic prophylaxis as an effective option for UTIs related to sexual activity, with fewer adverse events 1
The American Urological Association suggests cranberry products as a prophylaxis option for recurrent UTIs 1

The American Urological Association advises against surveillance urine testing in asymptomatic patients with recurrent UTIs 1
The American Urological Association recommends not treating asymptomatic bacteriuria in non-pregnant patients 1
The American Urological Association acknowledges that recurrent UTIs significantly impact quality of life, affecting social and sexual relationships, self-esteem, and work capacity 4

The American Urological Association advises against using fluoroquinolones as first-line empiric therapy due to increasing resistance and adverse effects 4
The American Urological Association warns that all antibiotics have potential risks, including nitrofurantoin, which has rare but serious risks of pulmonary and hepatic toxicity 1
The Centers for Disease Control and Prevention states that treatment of male sex partners has not been beneficial in preventing recurrence of BV and is not recommended 2, 3